Why the study?
Does TAVI or SAVR improve long-term clinical outcomes compared to medical therapy in elderly high-risk patients with severe aortic stenosis?
Does TAVI or SAVR improve long-term clinical outcomes compared to medical therapy in elderly high-risk patients with severe aortic stenosis?
In elderly high-risk patients with severe aortic stenosis, TAVI and SAVR offer comparable 5-year clinical outcomes, both significantly better than medical therapy.
Answers are grounded in this paper and cite their sources.
Supports TAVI/SAVR over MT in high-risk elderly severe AS; leaves open randomized confirmation of long-term equivalence.
Among high-risk patients with severe aortic stenosis, long-term clinical outcome through 5 years was comparable between patients allocated to SAVR or TAVI. In contrast, patients with MT had a dismal prognosis.
No takes yet. Share an insight, caveat, or question.
Pilgrim et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: